-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Johnson & Johnson's eye health business-Johnson & Johnson All Vision announced that its ACUVUE® Abiliti™ night-wear contact lens has been approved by the U.
S.
Food and Drug Administration (FDA)
.
This is the first and currently only FDA-approved contact lens for myopia management
"Johnson & Johnson All Vision has always been committed to changing the trajectory of eye health and reshaping the future of myopia in children
.
The approval of the Abiliti™ night-wearing contact lens by the FDA marks an important milestone for us to achieve this great vision.
Myopia is a chronic progressive disease and has become the greatest threat to eye health in the 21st century
.
Once children 12 years of age and younger suffer from myopia, they are very likely to develop high myopia, and may increase their risk of blindness in old age
Clinical studies have shown that contact lenses are a safe and effective treatment option for managing myopia
.
Abiliti™ night-wearing contact lenses are specially designed according to the individual's unique corneal shape to fit different eyes
The Abiliti™ night-wearing contact lens connects corneal topography, refractive error and other examinations with an innovative adaptation software
.
The software is a sophisticated and user-friendly tool for detecting the shape of the cornea and providing correct guidance to eye health professionals during the fitting process, thereby continuously achieving a 90% first fitting success rate
"The prevalence of myopia in children is rising
.
As optometrists, we are working at the forefront to deal with this epidemic that threatens the eye health of the next generation
Johnson & Johnson is actively cooperating to accelerate the research and development of innovative technologies and solutions in order to bring about changes in the prevention and control of myopia and change the development trajectory of eye health
.
Earlier this year, the company announced the launch of the first new guidelines for eye care professionals to provide advice on prevention and control of myopia for the evaluation, monitoring and treatment of myopia in children
Where consumers purchase Abiliti™ products for one year at a time, the company will provide a comprehensive eye health check for a child in difficulty through the Sight for Kids project
.
The Sight for Kids project is one of the most influential school eye health projects in the world.
